Larvol Delta - Arxx-Therapeutics-initiates-rstinhuman-trial-of-AX202--a-monoclonal-antibody-under-development-for-brotic-diseases

AX-202 - Arxx Therap, Cancer Research UK

https://pipelinereview.com/index.php/2023050983209/Antibodies/Arxx-Therapeutics-initiates-first-in-human-trial-of-AX-202-a-monoclonal-antibody-under-development-for-fibrotic-diseases.html

May 9, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev